Who we are

Dr Andy Herbert, BSc, PhD

Andy Herbert has worked in the biotechnology industry internationally for more than 30 years.  He has a detailed knowledge of pharmaceutical manufacturing, GMP, process and product development.  He specializes in helping companies through the challenges of developing products and processes that employ biotechnologies.

After receiving a doctorate in biochemical engineering sponsored by Unilever, he worked for five years in process development in ICI’s industrial fermentation and biochemicals division in the UK.  He moved to Canada in 1989 and spent nine years with Sanofi-Pasteur, ultimately taking responsibility for all vaccine development in Canada. He was part of teams that developed and licensed a highly effective acellular pertussis vaccine and the human cancer vaccine ImmuCyst® (for the treatment of superficial bladder cancer).  In 1998 he founded a biopharmaceutical engineering consulting company in Toronto and over the next eight years built a team which has assisted more than 30 different biotechnology client companies in Canada, USA, Mexico, Cuba and Argentina.

After moving to New Zealand in 2005 he took a role as General Manager Operations with ICPbio Ltd., leaving the firm in 2007 to set up as a consultant to biotechnology companies.  He works with a range of New Zealand and overseas companies including those developing pharmaceuticals, nutraceuticals, food ingredients, new processing technologies and services.  Andy was a board member of NZBIO for five years and chairman for two.   He sits on the board of The Bioprocessing Network, a focus group for bioprocessing  technologies in Australia.   His professional memberships include Biotech NZ, ISPE and PDA.